Merck Nears $1.3 Bln Cash Deal To Buy EyeBio, With Potential $1.7 Bln In Milestone Payments : Report
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
(RTTNews) – Merck & Co., Inc. (MRK) is nearing an agreement to buy a privately held ophthalmology biotechnology company Eyebiotech for $1.3 billion in cash, the Wall Street Journal reported citing people familiar with the matter.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2155522534-8510213a5205498c9cf10239a6d1542b.jpg "The 10 Best Alternatives to Craigslist")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1480323436-0009268132e143869758c3f6d2a4642b.jpg "<div>4 Basic Pointers When Investing Other People's Money</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1132711574-388eca9691b24bcea4b6ddac521bac25.jpg "Divorce Planning Checklist")
:max_bytes(150000):strip_icc():format(jpeg)/PaperworkatDesk-1a3837aec527439dbbf86d99a89611ba.jpg "2024 and 2025 Federal Income Tax Brackets, Standard Deductions, and Tax Rates")